Skip Navigation

European Heart Journal 1997 18(Supplement C):12-18; doi:10.1093/eurheartj/18.suppl_C.12
Copyright © 1997 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Janse, M. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Janse, M. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1997 The European Society of Cardiology

Why does atrial fibrillation occur?

M. J. Janse

Department of Clinical and Experimental Cardiology, Academic Medical Center, University of Amsterdam, and the Interuniversity Cardiology Institute The Netherlands

Correspondence: Michiel J. Janse, Department of Clinical and Experimental Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

Atrial fibrillation is often associated with atrial enlargement and stretch is known to cause electrophysiological alterations. Acute stretch may, depending on the moment at which it is applied, cause action potential shortening or induce both early and delayed afterdepolarizations which, when large enough, may initiate triggered premature action potentials. The effects of acute stretch may be very different from those of chronic stretch. In fact, in dogs with mitral valve disease in which progressive atrial enlargement, leading to atrial fibrillation, developed over a period of years, hardly any changes in transmembrane potential characteristics were found. In contrast, marked fibrosis developed which could favour re-entry because of slow fragmented conduction.

A number of electrophysiological changes have been found in isolated preparations from human atria that had been fibrillating. Action potentials had a shorter duration and a triangular configuration in contrast to action potentials from normal atria that mostly showed a distinct plateau. Refractory periods were also shorter and the normal rate adaptation of the refractory period disappeared, so that, following a slowing of the heart rate, the refractory period did not prolong. These changes largely seem to be the result of prolonged episodes of rapid atrial activity and may be called electrophysiological remodelling. In addition, a marked dispersion refractoriness has been found which might be due to different factors, such as fibrosis and local denervation.

It is likely that atrial dilatation and fibrosis are important factors in the occurrence and maintenance of atrial fibrillation. In an enlarged atrium, multiple re-entrant circuits can co-exist. Fibrosis leads to inhomogeneities in both conduction and refractoriness. Finally, the arrhythmia itself causes persistent shortening of refractoriness. All of these changes favour re-entry.

Key Words: Action potential • refractory period • stretch • fibrosis • dilatation • electrical remodelling • re-entry


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
E. M. Kallergis, E. G. Manios, E. M. Kanoupakis, H. E. Mavrakis, D. A. Arfanakis, N. E. Maliaraki, C. E. Lathourakis, G. I. Chlouverakis, and P. E. Vardas
Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation biochemical assessment of collagen type-I turnover.
J. Am. Coll. Cardiol., July 15, 2008; 52(3): 211 - 215.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
A Boldt, U Wetzel, J Lauschke, J Weigl, J Gummert, G Hindricks, H Kottkamp, and S Dhein
Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease
Heart, April 1, 2004; 90(4): 400 - 405.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Ammer, G.u. Lehmann, A. Plewan, K. Puetter, and E. Alt
Marked reduction in atrial defibrillation thresholds with repeated internal cardioversion
J. Am. Coll. Cardiol., November 1, 1999; 34(5): 1569 - 1576.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.